Diskussion:National Cholesterol Education Program

offiziell bekanntgegebene finanzielle Abhängigkeiten der Autoren der aktuellen Richtlinien:

ATP III Update 2004: Financial Disclosure

Dr. Grundy has received honoraria from Merck, Pfizer, Sankyo, Bayer, Merck/Schering-Plough, Kos, Abbott, Bristol-Myers Squibb, and AstraZeneca; he has received research grants from Merck, Abbott, and Glaxo Smith Kline.

Dr. Cleeman has no financial relationships to disclose.

Dr. Bairey Merz has received lecture honoraria from Pfizer, Merck, and Kos; she has served as a consultant for Pfizer, Bayer, and EHC (Merck); she has received unrestricted institutional grants for Continuing Medical Education from Pfizer, Procter & Gamble, Novartis, Wyeth, AstraZeneca, and Bristol-Myers Squibb Medical Imaging; she has received a research grant from Merck; she has stock in Boston Scientific, IVAX, Eli Lilly, Medtronic, Johnson & Johnson, SCIPIE Insurance, ATS Medical, and Biosite.

Dr. Brewer has received honoraria from AstraZeneca, Pfizer, Lipid Sciences, Merck, Merck/Schering-Plough, Fournier, Tularik, Esperion, and Novartis; he has served as a consultant for AstraZeneca, Pfizer, Lipid Sciences, Merck, Merck/Schering-Plough, Fournier, Tularik, Sankyo, and Novartis.

Dr. Clark has received honoraria for educational presentations from Abbott, AstraZeneca, Bristol-Myers Squibb, Merck, and Pfizer; he has received grant/research support from Abbott, AstraZeneca, Bristol-Myers Squibb, Merck, and Pfizer.

Dr. Hunninghake has received honoraria for consulting and speakers bureau from AstraZeneca, Merck, Merck/Schering-Plough, and Pfizer, and for consulting from Kos; he has received research grants from AstraZeneca, Bristol-Myers Squibb, Kos, Merck, Merck/Schering-Plough, Novartis, and Pfizer.

Dr. Pasternak has served as a speaker for Pfizer, Merck, Merck/Schering-Plough, Takeda, Kos, BMS-Sanofi, and Novartis; he has served as a consultant for Merck, Merck/Schering-Plough, Sanofi, Pfizer Health Solutions, Johnson & Johnson-Merck, and AstraZeneca.

Dr. Smith has received institutional research support from Merck; he has stock in Medtronic and Johnson & Johnson.

Dr. Stone has received honoraria for educational lectures from Abbott, AstraZeneca, Bristol-Myers Squibb, Kos, Merck, Merck/Schering-Plough, Novartis, Pfizer, Reliant, and Sankyo; he has served as a consultant for Abbott, Merck, Merck/Schering-Plough, Pfizer, and Reliant.

Hans123 16:10, 25. Okt 2005 (CEST)

Defekte Weblinks

Dieser Baustein verhindert die automatische Archivierung dieses Abschnitts und seiner Unterabschnitte.

Die folgenden Weblinks wurden von einem Bot („GiftBot“) als nicht erreichbar erkannt.
Ausführliche Erläuterungen und Hilfe zur korrekten Behebung dieser Fehler finden sich auf Wikipedia:Defekte Weblinks. Ist ein von einem Bot als defekt gemeldeter externer Link doch erreichbar, dann bitte berichten – wie auch sonstige Probleme.

• http://www.nhlbi.nih.gov/about/ncep/
  • Vielleicht ist eine archivierte Version geeignet: archive.orghttp://giftbot.dwl.invalid/http://www.nhlbi.nih.gov/about/ncep/
• http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm
  • Vielleicht ist eine archivierte Version geeignet: archive.orghttp://giftbot.dwl.invalid/http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm
  • Artikel mit gleicher URL: 931 1754491 (aktuell)
• http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04_disclose.htm
  • Vielleicht ist eine archivierte Version geeignet: archive.orghttp://giftbot.dwl.invalid/http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04_disclose.htm

– GiftBot (Diskussion) 08:24, 23. Dez. 2015 (CET)